Bdr Lifesciences Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is RELUGOLIX, with a corresponding US DMF Number 40209.
Remarkably, this DMF maintains an Active status since its submission on July 25, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 22, 2024, and payment made on July 19, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II